Form D · Other
REFRAME HEALTH, INC.
San Francisco, CA · CIK 0001966671
Offering snapshot reported Apr 14, 2026 · SEC filing
- Reported sold
- $4.31M Offering amount: $4.71M
- Investors reported
- 25 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 5, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 14, 2026 | Initial | $4,306,883 | No comparison | 25 | SEC filing |
| Jul 25, 2023 | Amendment | $5,327,021 | $225,000vs Jun 28, 2023 | 48 | SEC filing |
| Jun 28, 2023 | Amendment | $5,102,021 | $298,527vs Feb 22, 2023 | 46 | SEC filing |
| Feb 22, 2023 | Initial | $4,803,494 | No comparison | 44 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-580363
Sale and issuance of Series Seed-2 and Series Seed-3 Preferred Stock ("Series Seed") and the underlying shares of Common Stock issuable upon conversion of Series Seed.
Source: Form D, filed Apr 14, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jessica Leigh Bell | Director, Executive |
| Andrew Mitchell | Director |
| Cornelis Edward Johannes Van Der Wal | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
C/O Reframe Health, Inc. 447 Sutter St, Ste 405 #247
San Francisco, CA, 94108
San Francisco, CA, 94108